![a photo of a person testing the water of a stream](https://www.uc.edu/news/articles/2024/04/n21243224/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1712940693013.jpg)
New York Times, National Geographic: EPA says ‘forever chemicals’ must be removed from tap water
The University of Cincinnati's Susan Pinney was featured in the New York Times and National Geographic in stories on the EPA's recent requirement that municipal water systems remove six synthetic chemicals linked to cancer and other health problems that are present in the tap water of hundreds of millions of Americans.
The new rule states water providers must reduce levels of industrial pollutants perfluoroalkyl and polyfluoroalkyl substances, known collectively as PFAS or "forever chemicals," to nearly zero.
Pinney, professor in the Department of Environmental & Public Health Sciences in UC's College of Medicine, director of the Center for Environmental Genetics and associate director of population science in the University of Cincinnati Cancer Center, is a nationally known expert on forever chemicals who has studied the topic for years.
“The evidence of PFAS being dangerous goes all the way back to the 1980s when chemists were doing studies, noticed that PFAS had the same chemical structure as other dangerous chemicals and they reported on it,” Pinney says. “It’s taken a very long time for us to recognize it as a human toxin. Meanwhile, all of these toxins got into our environment, and it’s going to take a long time before they leave.”
The Times cited Pinney's recently published research that found exposure to PFAS may delay the onset of puberty in girls. She said the number of people exposed to PFAS nationwide is "mind boggling."
“Puberty is a window of susceptibility,” Pinney said. “Environmental exposures during puberty, not just to PFAS, but anything, have more of a potential for a long-term health effect. What these have done is extended the window of susceptibility, and it makes them more vulnerable for a longer period of time.”
Pinney told National Geographic she "applauds" the EPA decision.
“It’s in line with what we know about the health effects of PFAS,” Pinney said.
Read the New York Times story.
Read the National Geographic story.
Pinney's research was also featured in a Columbus Dispatch story on the new EPA rule. Read the Dispatch story.
Featured photo at top of water sampling. Photo/iStock/vitranc.
Related Stories
New York Times, National Geographic: EPA says ‘forever chemicals’ must be removed from tap water
April 11, 2024
The University of Cincinnati's Susan Pinney was featured in the New York Times and National Geographic in stories on the EPA's recent requirement that municipal water systems remove six synthetic chemicals linked to cancer and other health problems that are present in the tap water of hundreds of millions of Americans.
CureToday: UC enrolling patients for glioblastoma trial
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
Physics World names UC, Cincinnati Children's study among top 10 Breakthroughs of 2022
December 8, 2022
Physics World recognized the University of Cincinnati's first-in-human trial of FLASH radiotherapy as one of the Top 10 Breakthroughs of the Year for 2022.
Local 12: Researcher working to help patients with tough-to-beat pancreatic cancer
February 8, 2023
Local 12 highlighted the University of Cincinnati's Andrew Waters and his research into novel treatments for pancreatic cancer.
Wall Street Journal: More women with breast cancer could skip harsh radiation
February 16, 2023
The University of Cincinnati Cancer Center's Sara Medek and Elizabeth Shaughnessy were featured in a Wall Street Journal article commenting on a recent study that found more older women with low-risk breast cancer could forgo radiation after surgery to avoid further side effects.
Dermatology Times features UC research of nail squamous cell carcinoma treatment
June 9, 2022
Dermatology Times featured recent research by University of Cincinnati researchers that showed a low recurrence rate of nail squamous cell carcinoma when treated with surgical approaches other than amputation.
GEN News: Biomarker discovery to help predict breast cancer outcomes
September 7, 2022
GEN News highlighted recent University of Cincinnati and Cincinnati Children's Hospital Medical Center research on metabolic signatures that help predict breast cancer outcomes and could open avenues for new treatments.
Healio: Sleep, diet among keys to preserving cognitive function during cancer survivorship
September 25, 2023
The University of Cincinnati's Rhonna Shatz, DO, spoke with Healio about cognitive function during cancer survivorship.
Local 12, Business Courier highlight Blood Cancer Healing Center
February 19, 2024
Local 12 and the Cincinnati Business Courier highlighted the University of Cincinnati Cancer Center's Blood Cancer Healing Center, a comprehensive all-in-one facility dedicated solely to advancing research, treatment and wellness for blood cancer patients, opening this summer.
OncLive and Targeted Oncology: Drug yields long-lasting benefits to treat PEComa tumors
March 22, 2024
OncLive and Targeted Oncology covered research presented by the University of Cincinnati's Thomas Herzog that found patients with perivascular epithelioid sarcoma (PEComa) of gynecologic or peritoneal origin experienced rapid, durable responses when treated with the drug nab-sirolimus.